This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CVS-Caremark Split Could Drive Up Stock: Analyst

NEW YORK ( TheStreet) -- A breakup between CVS (CVS - Get Report)and its Caremark unit could present a big upside for the stock, according to an analyst.

If the two divisions were to split, it could mean as much as 30% upside for the stock, Credit Suisse analyst Edward Kelly wrote in a note.

But just how likely is a split between CVS and Caremark? Kelly noted that if Caremark's performance doesn't improve over the next year it could be highly likely.

"We find CVS's continued mismanagement of Caremark and its lack of insight into the underlying issues disturbing," he wrote. "That being said, we believe overwhelmingly negative investor sentiment has created a compelling risk/reward set-up in the stock. We continue to believe CVS's problems are fixable."

While Caremark is experiencing some fundamental problems, Kelly still believes it's an attractive asset for a potential buyer. He also said that while a sale would be the best bet for CVS, a spin-off could also help the drugstore.

In its fourth quarter, CVS reported lower profits and revenue and said it expects profit at its Caremark pharmacy benefits management to shrink further in 2011. This will mark the second consecutive year of profit declines at the division.

Wall Street expected the company would begin to see improvements at Caremark, but CVS said a new multi-year contract with Aetna will drag on results.

Other issues affecting Caremark include lower payments from pharmacy benefits programs for federal employees, less profitable contract renewals, and expenses related to cost cuts. CVS also said adjusted profit per prescription will continue to decline, moving closer to the levels reported by Caremark's competitors.

The company does expect Caremark profit to start to grow in 2012.

CVS acquired Caremark in 2007 for $27 billion.

--Written by Jeanine Poggi in New York.

>To contact the writer of this article, click here: Jeanine Poggi.

>To follow the writer on Twitter, go to

>To submit a news tip, send an email to:

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CVS $101.45 0.95%
AAPL $93.64 -0.11%
FB $118.57 0.84%
GOOG $698.21 0.75%
TSLA $241.80 0.43%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs